Expanding use of rucaparib as maintenance therapy in recurrent ovarian cancer: updates from the ARIEL3 trial

Federica Tomao, Patrizia Vici, Silverio Tomao

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Pages (from-to)616-617
Number of pages2
JournalThe Lancet Oncology
Issue number5
Publication statusPublished - May 2020

ASJC Scopus subject areas

  • Oncology

Cite this